Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Mar 22, 2024 8:17am
92 Views
Post# 35946620

"subsidiary" of Astrazeneca acquird Fusion Pharma-Hamilton

"subsidiary" of Astrazeneca acquird Fusion Pharma-Hamilton

That subsidiary in Canada is not publicly listed just like Pfizer's subsidiary in Kirkland Quebec is not publicly listed because it's a 'subsidiary'.    Intercompany transfers, funding accounts of Freightliner in South America or sweeping accounts of Freightline in South America by Daimler Chrysler in Windsor.   

Pfizer incorporated in the U.S. does the same things within their internal banking operations but they can't fund Pfizer Canada in Kirkland Quebec to consumate the deal with LABS until they have clearance from the DEA from schedule 1 to 3.   

Reread the article that gave FUSN a $10 gap on the news, it was a subsidiary.

That's how Pfizer can conduct clinical trials with LABS in Canada and not breech U.S. Federal law because they do it 'in house' through their Canadian subsidiary which is IN FACT a CRA registered corporation.   

Have a nice day everyone!

<< Previous
Bullboard Posts
Next >>